#DR. DROPThere are over 100 identified cannabinoids in Cannabis Sativa.BCP is a constituent of the essential oils of numerous spice and food plants and a major component in Cannabis.Complete CB2 agonist, as opposed to its CBD cousin, which is a partial agonist.13 Lives Dr. Drop Appropriately dosed to achieve therapeutic effect.Achieve relief from the following:AnxietyCortisol managementDepressionAdrenal functionAcute painChronic painAnti-inflammatory and immune supportAids in stress reductionCardiovascular and neurological function supportImproves skin for a smoother complexionProvides digestion, liver. respiratory and antioxidant supportContains: (BCP β-Caryophyllene) 600mg/ml WHAT IS BCP?β-caryophyllene (BCP), a potent non-psychoactive cannabinoid and a full agonist of the CB2 (cannabinoid type-2) receptor, while cannabidiol (CBD) is only a partial agonist of CB2. BCP is found in the essential oils of the following plants at (Ahmed et al. 2000; Alma et al. 2007; Bernotienë et al. 2004; Calvo-Irabien et al. 2009; Jirovetz et al.2002; Kaul et al. 2003; Leandro et al. 2012; Prashar et al. 2004; Ormeño et al. 2008; Silva et al. 2004; Singh et al. 2006; Vito & Steinemann 1997): Marijuana flower at 37.5%Capoiba at 35%Malabrathum at 25.3%Basil at 19.8%Clove bud at 19.5%Oregano at 15.7%Hops at 14.5%True cinnamon at 11.1%Ylang-ylang at 10.7%Rosemary at 8.3%Black caraway at 7.8%Lavender at 7.55%Black pepper at 7.29% BCP VS CBDThe Ki value of a molecule represents its receptor affinity (strength). The smaller theKi the less molecule is needed, thus, the stronger it is. BCP has a mean Ki = 320nM for CB2, while CBD has a Ki = 2860nM for CB2 (Abcam 2019; Gertsch et al. 2008). This means BCP requires approximately 11 times less molecule to activate the CB2 receptor than CBD. BCP activates 100% of the CB2 receptor, while CBD activates approximately only 60% of the CB2. This makes BCP far superior to CBD.